VBI pits hepatitis B candidate against GlaxoSmithKline's Engerix-B in head-to-head phase 3
admin 19th December 2017 Uncategorised 0After getting go-aheads from multiple regulatory agencies, VBI Vaccines started phase 3 testing of its hepatitis B vaccine Sci-B-Vac against its future rival, GSK’s Engerix-B, aiming to file for approvals in 2019.
More: VBI pits hepatitis B candidate against GlaxoSmithKline's Engerix-B in head-to-head phase 3
Source: fierce